Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Classical hematology 1Breast 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Small Cell Lung Carcinoma 2Uterine Cervical Neoplasms 1Thrombocytopenia 1Primary Myelofibrosis 1Pathologic Complete Response 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 7Carboplatin 5Cisplatin 4Drug Therapy 3Taxes 2Specimen Handling 2SS1(dsFv)PE38 2Polymerase Chain Reaction 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Hyperthermic Intraperitoneal Chemotherapy 2Gene Expression Profiling 2Fluorouracil 2Doxorubicin 2Cyclophosphamide 2130-nm albumin-bound paclitaxel 2tremelimumab 1tocilizumab 1tinostamustine 1sodium thiosulfate 1selinexor 1rucaparib 1olaparib 1motexafin lutetium 1liposomal doxorubicin 1fludarabine 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Tretinoin × Thoracic × Clear all
NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡